StockNews.com upgraded shares of Avanos Medical (NYSE:AVNS – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday.
Avanos Medical Stock Up 0.0 %
NYSE:AVNS opened at $22.63 on Friday. The company has a market cap of $1.04 billion, a PE ratio of -17.02 and a beta of 0.91. Avanos Medical has a twelve month low of $17.39 and a twelve month high of $25.36. The company has a current ratio of 2.28, a quick ratio of 1.49 and a debt-to-equity ratio of 0.13. The company’s 50 day moving average is $23.42 and its two-hundred day moving average is $21.49.
Avanos Medical (NYSE:AVNS – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.29 by $0.05. The business had revenue of $171.70 million for the quarter, compared to the consensus estimate of $170.67 million. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The business’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.24 EPS. Analysts anticipate that Avanos Medical will post 1.39 EPS for the current year.
Institutional Trading of Avanos Medical
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
- Five stocks we like better than Avanos Medical
- How is Compound Interest Calculated?
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- The How and Why of Investing in Gold Stocks
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- What Are Trending Stocks? Trending Stocks Explained
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.